B. Bodey et al., CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF KI-67 AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN CHILDHOOD PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS, Anticancer research, 17(1A), 1997, pp. 189-196
The cell proliferation activity of sixteen childhood primitive neuroec
todermal tumors (PNETs) was observed immunocytochemically, to determin
e the cell kinetics and cell proliferation activity of these relativel
y undifferentiated, malignant brain tumors. Two mouse anti-human monoc
lonal antibodies (MoABs) were employed for the detection of the nuclea
r antigens (Ki-67) present during proliferation in frozen sections and
proliferating cell nuclear antigen (PCNA) expression in formalin fixe
d, paraffin embedded tissue sections. A sensitive four step, indirect,
streptavidin-biotin, alkaline phosphatase (AP) conjugated, immunocyto
chemical experimental technique, was used. The nuclear anti-Ki-67 MoAB
which binds to a special nuclear antigen, identified its expression o
nly in proliferating cells. This nuclear antigen was detectable during
the whole mitotic cycle of all malignant and fast proliferating cells
, only absent between and during phases G(0) (resting phase) and the f
irst gap phase (G(1)). The mean labelling index (MLI) was defined as t
he percentage of Ki-67 and PCNA antigen positive cells of the total nu
mber counted. The MLI for the PNETs ranged between 1.4% and 11.6%, wit
h a mean MLI of 6.2% for Ki-67; and between 3.2% and 16.8% with a mean
of 9.74% for PCNA. All observed PNETs demonstrated heterogeneous nucl
ear stainings, but the highest MLIs were found among the poorly differ
entiated classic medulloblastomas (over 30% for the Ki-67 antigen and
46% for PCNA). MLIs were low in 5/13 PNETs (under 4% for antigen Ki-67
and 9.4% for PCNA) and in this group we defined our lowest (1.4%) MLI
, suggesting the presence of in vivo neuritogens of these undifferenti
ated, embryonal tumors. MLIs in 6/13 PNETs were intermediated in magni
tude. The MLIs were higher in two PNETs with clear cellular differenti
ation towards an ependymal (10.4%) and melanocytic (8.8%) direction. F
ormation of astrocytes within the tumor mass did not affect the interm
ediate character of the MLI (7.8%). The prognosis of every interactive
tumor is obviously correlated with its proliferation activity and cel
l kinetics. The clinical significance of these parameters is great sin
ce they provide direct information concerning the growth characteristi
cs of an intracranial tumor.